Building a pharma brand does not require owning a factory. Most people know this in theory. In practice, they underestimate both what third-party manufacturing can do for them and what can go wrong when they choose the wrong manufacturer.

This is a guide for people who are seriously considering it. Maybe you are launching a nutraceutical brand. Maybe you have a PCD franchise business and want your own product line. Maybe you are a wellness company wanting to add supplements without building manufacturing infrastructure. All three situations involve the same core decision: which manufacturer, on what terms, with what quality guarantees.

This guide answers those questions honestly. Including the parts most manufacturers would prefer you not ask about upfront.

---

What Third-Party Manufacturing Actually Means

Third-party manufacturing — also called contract manufacturing or loan licensing — is when a licensed pharmaceutical manufacturer produces products on your behalf, using your brand name. You bring the product concept, they bring the facility, equipment, regulatory approvals, and production expertise.

You own the brand. They own the factory.

The relationship works because building a WHO-GMP manufacturing facility is expensive — crores in capital expenditure, years of regulatory work, specialized staff. For a brand that wants to sell 10,000 units of a multivitamin per month, building their own factory makes no financial sense. The manufacturer already has the capacity. They fill it with your order alongside others.

The legal structure uses a loan license, where the brand (you) holds a drug license and the manufacturer has a separate manufacturing license. The product is sold under your brand, with your address as the marketer, and the manufacturer's details as the actual manufacturing site.

---

When It Makes Sense — and When It Doesn't

Third-party manufacturing is the right move when:

• ✓You want to launch a product line without capital investment in infrastructure
• ✓You are testing market demand before committing to larger production
• ✓Your current in-house capacity cannot meet growing demand
• ✓You want to add a product category your facility is not set up for
• ✓You are a PCD franchise partner wanting to add proprietary branded products to your range

It is the wrong move when:

• Your product requires manufacturing processes so specialized that very few facilities can handle it
• You need extremely rapid production turnarounds that a shared facility cannot guarantee
• Your margins are so thin that any production variance destroys your economics

For most nutraceutical, general pharma, and wellness product categories, third-party manufacturing is genuinely the more practical path — at least until you are moving enough volume to justify your own facility.

---

The Indian Pharma Manufacturing Landscape

India has over 10,000 WHO-GMP certified pharma manufacturing units. That sounds like plenty of options. The reality is that quality varies enormously, and price is a poor proxy for quality in this industry.

The Chandigarh–Mohali–Panchkula pharmaceutical corridor — sometimes called the Pharma Hub of North India — has a high concentration of quality manufacturers. Baddi in Himachal Pradesh is another major cluster. These regions have manufacturing density that drives both competition (good for buyers) and a skilled labor pool (good for output consistency).

---

What to Check Before You Sign

Manufacturing License and WHO-GMP Certificate

Start with the basics. Ask for the manufacturer's current drug manufacturing license and WHO-GMP certificate. Check that the license covers the specific dosage forms you need — tablets, capsules, syrups, injections, creams, and powders are all different categories. A manufacturer licensed for oral solids cannot produce injections.

For nutraceutical or herbal products, check whether the facility holds FSSAI registration and whether they have handled herbal formulations before. Herbal manufacturing has specific equipment requirements and contamination risks that general pharma facilities may not handle properly.

Product-Specific Capability

The manufacturer's capability statement is not the same as their actual experience with your product type. Ask specifically:

• Have you manufactured this product type before? Can you show batch records or a CoA from a comparable product?
• What is your batch size range? (Minimum and maximum)
• What is your capacity utilization? A facility running at 95% will struggle to prioritize your order.
• What is your typical lead time from order confirmation to dispatch?

A good manufacturer will answer these directly. Vague or deflecting answers are data.

Quality Control Infrastructure

Ask about their in-house QC laboratory. Do they test raw materials on intake? Do they test finished goods before release? What are their out-of-spec procedures?

A serious manufacturer will show you a sample CoA (Certificate of Analysis) for a product they currently make. A real CoA includes batch number, manufacturing date, expiry date, the specific tests performed, results, and the acceptable range for each parameter. If a manufacturer offers a CoA with no actual test data — just a declaration — that is not a CoA. It is a piece of paper.

Stability Testing

Stability testing confirms that a product retains its potency, appearance, and safety profile throughout its shelf life. Many smaller manufacturers skip this or say they will "handle it later." If you are putting your name on a product, you need stability data. Ask whether the manufacturer will provide it, or whether you need to commission it separately.

What Your Manufacturing Agreement Must Cover

1. Product formula ownership — who holds it and what happens if the contract ends
2. Quality standards — what CoA parameters apply, what the rejection criteria are
3. MOQs and pricing — including revision clauses for raw material cost changes
4. Lead times and penalties for delayed production
5. Batch record retention — how long the manufacturer keeps documentation
6. Dispute resolution — jurisdiction and notice periods

If any manufacturer pushes back on putting things in writing, stop there.

---

Product Categories in Demand Right Now

Nutraceuticals and Health Supplements

The fastest-growing segment. Multivitamins, omega-3, protein supplements, immunity boosters, hair and skin supplements, gut health products. Consumer awareness has jumped significantly since 2020, and the market is far from saturated outside metro cities. Products with clinical evidence and proper standardization of active ingredients command better margins and better retention.

Derma Products

Dermatologist-recommended creams, antifungals, anti-acne treatments, and sunscreens. The OTC cosmeceutical segment is growing fast. Derma manufacturing requires specific equipment and environmental controls — verify capability carefully.

Ayurvedic and Herbal Formulations

Ashwagandha, Shilajit, Triphala, Shatavari, herbal immunity blends. Demand has been consistent. The regulatory framework differs from allopathic products — make sure your manufacturer holds the relevant AYUSH manufacturing license if you are in this space.

Pediatric and Gynae Products

These require careful formulation — dosing accuracy is critical for pediatric products. Look for manufacturers with specific experience in these segments, not just general pharma capacity.

Orthopedic and Analgesic Products

Consistently demanded. Calcium supplements, joint-care products, NSAIDs, topical analgesics. For a PCD franchise partner looking to add a proprietary line, ortho products are a reliable starting point.

---

Cost Structure: What You Are Actually Paying For

Third-party manufacturing costs depend on formulation complexity, batch size, packaging type, and testing requirements. For a standard multivitamin tablet, costs in India currently range from ₹1.50 to ₹4.50 per tablet, depending on formulation, batch size, and packaging. Premium nutraceuticals with clinically studied actives go higher.

What you should not do is choose purely on price. The difference between a ₹2.00 and ₹2.50 per tablet quote might save you ₹5 lakh on a large batch. But if the cheaper manufacturer has a batch failure rate of 3%, you have a far larger problem than ₹5 lakh.

---

Private Label vs. Custom Formulation

Private label means you take a product the manufacturer already makes — existing formula, existing stability data, existing regulatory history — and put your brand name on it. This is faster (30–45 days to first production), cheaper, and lower risk. The trade-off: the same formula might be available to other brands through the same facility.

Custom formulation means you develop a unique product — a specific combination of ingredients, a particular release profile, a proprietary blend. This takes 3–6 months for development, stability testing, and regulatory filing. The advantage is genuine differentiation: your formula is yours.

For most brands starting out, private label is the sensible first step. Build your distribution, understand what moves, then invest in custom development for products where differentiation genuinely matters.

---

Working With a Manufacturer in the Chandigarh Belt

If you are evaluating manufacturers in the Chandigarh–Mohali–Panchkula corridor, the regional density has a practical advantage: you can visit the facility before committing. This matters.

A factory visit tells you things no document can. The cleanliness of the production floor. Whether workers wear proper protective equipment. Whether the QC lab is actually being used. Whether the regulatory files are organized or buried in a cabinet.

Any manufacturer who is reluctant to have you visit the facility before you sign an agreement has given you all the information you need.

---

Common Traps in Third-Party Manufacturing

---

How to Get Started

1. Get your drug license — required to be the brand/marketer on a third-party manufactured product
2. Define your product clearly — form, dosage, packaging, pack size, and target market
3. Shortlist 3–5 manufacturers based on capability, location, and initial conversation quality
4. Request facility visit and documentation — license, WHO-GMP certificate, sample CoA
5. Get quotes with full specifications — no verbal quotes, ever
6. Review and sign a proper manufacturing agreement covering all six points listed in Section 4
7. Approve samples before authorizing the full production run
8. Verify the CoA against specifications before accepting the batch

From first conversation to first production batch, private label typically takes 6–12 weeks. Custom formulation adds time. Plan accordingly.